JN6-25836-72867
4 vaccinations
2 coded responses
35 check-ins
2 free-text entries
2 call cases
- Sex
- —
- Age at first dose
- 26-30
- ZIP prefix
- 989 / WA
- Registered
- 2020-12-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Dose 1 — Pfizer-BioNTech
-
2020-12-20
Registered in v-safe
-
2020-12-20
Survey response — days 1–6 daily, dose 1MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · Fatigue or tiredness, DiarrheaFree text: Last night was very sweatyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fever · Fatigue or tirednessAdult check-in
-
2020-12-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, Abdominal painAdult check-in
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2021-01-02
- 2021-01-09
-
2021-01-10
Dose 2 — Pfizer-BioNTech
-
2021-01-10
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-16
- 2021-01-17
- 2021-01-24
- 2021-01-31
- 2021-02-07
- 2021-02-14
- 2021-02-21
- 2021-04-11
- 2021-07-11
-
2021-08-26
Dose 3 — Pfizer-BioNTech
- 2021-09-28
- 2021-09-30
- 2021-10-07
- 2021-11-25
- 2022-02-26
- 2022-08-28
-
2022-09-09
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-04
- 2022-10-09
-
2022-10-21
Survey response — day 42, dose 4MedDRA: Cough, Medical counselling, Nasopharyngitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Cold and cough · Healthcare visit (other): Nurse callMedDRA releases: 2024-11 · check-in free text available
-
2022-10-21
Report sent to call center — day 42, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-10-25
- 2022-12-11
- 2023-03-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-10 | Pfizer-BioNTech | |
| 3 | 2021-08-26 | Pfizer-BioNTech | No |
| 4 | 2022-09-09 | Pfizer-BioNTech | Flu |
Call center
2 call center cases
1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Last night was very sweaty
Release 12 — day 42, dose 4
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release